Images List Premium Download Classic

Hypertension

Hypertension-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Vascular calcification prevention and treatment
Summit Innovation Labs Llc
February 15, 2018 - N°20180042962

The invention encompasses compositions and methods for effectively interfering, reducing and preventing conversion of vascular smooth muscle cells (vsmcs) and circulating stem cells to osteoblastic bone-like cells, thereby reducing and/or preventing vascular calcification (vc) or calcium mineral (hydroxyapatite) deposition in the vasculature. The severity and extent of calcification in the major arteries reflect atherosclerotic plaque burden and strongly predict ...
Metabolic syndrome treatment
Arkay Therapeutics, Llc
February 15, 2018 - N°20180042945

Formulations and methods of providing an orally-active anti-metabolic disease fixed dose combinations (fdc) for use as personalized medicine to treat different components of the metabolic syndrome or insulin resistance syndrome such as type ii diabetes, hypertension, hyperlipidemia and obesity are disclosed. Pharmaceutical compositions of anti-inflammatory centric drug formulations and methods comprising of nsaids in general and selective cox-2 inhibitors in ...
Methods of treating cancers, autoimmune disorders, and other conditions associated with chronic inflammation
Mymd Pharmaceuticals, Inc.
February 15, 2018 - N°20180042909

In one aspect, a method of treating a disorder associated with chronic inflammation includes administering to an individual in need thereof a therapeutically effective amount of isomyosmine or a pharmaceutically acceptable salt thereof. In some aspects, the disorder is a cancer, an autoimmune disorder, hypertension, or autism. In other aspects, isomyosmine is administered to treat viral infections or disorders associated ...
Hypertension Patent Pack
Download 166+ patent application PDFs
Hypertension Patent Applications
Download 166+ Hypertension-related PDFs
For professional research & prior art discovery
inventor
  • 166+ full patent PDF documents of Hypertension-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Pain relief salt composition and method
February 08, 2018 - N°20180036343

A pain relief salt composition. An embodiment of the composition includes a blend of proprietary essential oils mixed with epsom salt and dead sea salt. The proprietary essential oils may include lavender oil, lemongrass oil, rosemary oil, patchouli oil, and ginger root oil. The pain relief salt composition is added to a bath to produce a pain relief salt bath. ...
Pharmaceutical for prophylaxis or treatment of hypertension
Daiichi Sankyo Company, Limited
February 08, 2018 - N°20180036281

A pharmaceutical for the prophylaxis or treatment of hypertension or a disease derived from hypertension. The pharmaceutical is characterized by comprising (i) a specific mineralocorticoid receptor antagonist and (ii) one or more components selected from the following components (a) to (c), for administration simultaneously or separately at a time interval: (a) an angiotensin ii receptor antagonist, (b) a calcium antagonist, ...
Methods, compounds, and compositions for the treatment of angiotensin-related diseases
University Of Southern California
February 01, 2018 - N°20180030042

Disclosed are small molecule non-peptidic compounds, as well as methods and compositions for the treatment of angiotensin-related diseases and disorders, including cardiovascular diseases, metabolic diseases, gastrointestinal diseases, renal diseases, inflammatory/autoimmune diseases, neurological diseases, bone marrow diseases and cancer. In particular, the invention provides compounds, methods and compositions for the treatment of metabolic diseases and disorders, such as diabetes mellitus, ...
Hypertension Patent Pack
Download 166+ patent application PDFs
Hypertension Patent Applications
Download 166+ Hypertension-related PDFs
For professional research & prior art discovery
inventor
  • 166+ full patent PDF documents of Hypertension-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
System and method for optogenetic therapy
Circuit Therapeutics, Inc.
February 01, 2018 - N°20180028832

Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitive proteins to specific cells or defined cell populations. In particular ...
Vagus nerve and carotid baroreceptor stimulation system
Cyberonics, Inc.
February 01, 2018 - N°20180028817

Systems and methods are provided for delivering vagus nerve stimulation and carotid baroreceptor stimulation to patients for treating chronic heart failure and hypertension. The vagus nerve stimulation and carotid baroreceptor stimulation therapies may be provided using a single implantable pulse generator, which can coordinate delivery of the therapies.
Liquid formulation
Luoda Pharma Pty Ltd
February 01, 2018 - N°20180028665

The invention relates to a liquid formulation comprising propylene glycol and an effective amount of an inodilator, an angiotensin converting enzyme inhibitor, or a combination of an inodilator and an angiotensin converting enzyme inhibitor and to use of the formulation for treating cardiac disease and/or hypertension.
Methods and systems for treating hypertension using an implantable electroacupuncture device
Valencia Technologies Corporation
January 25, 2018 - N°20180021566

An electroacupuncture device for treating hypertension in a patient includes 1) a housing configured to be implanted beneath a skin surface of the patient at an acupoint corresponding to a target tissue location within the patient, the acupoint comprising at least one of pc5, pc6, st36, and st37, 2) a central electrode of a first polarity and centrally located and substantially planar ...
Inhibitors of the renal outer medullary potassium channel
Merck Sharp & Dohme Corp.
January 18, 2018 - N°20180016263

The present invention provides compounds of formula (i); and the pharmaceutically acceptable salts thereof, which are inhibitors of the romk (kir1. 1) channel. The compounds may be used as diuretic and/or natriuretic agents and for the therapy and prophylaxis of medical conditions including cardiovascular diseases such as hypertension, heart failure and chronic kidney disease and conditions associated with excessive salt ...
Treprostinil derivatives and compositions and uses thereof
Corsair Pharma, Inc.
January 18, 2018 - N°20180016222

The present disclosure provides treprostinil derivatives that can act as prodrugs of treprostinil. The treprostinil derivatives can be used to treat any conditions responsive to treatment with treprostinil, including pulmonary hypertension, such as pulmonary arterial hypertension.
System and method for relieving hypertension
January 18, 2018 - N°20180015283

A system and method for relieving hypertension includes an energy wave generator set an energy wave's frequency control mode for controlling and generating energy waves with correspond energy densities in multiple energy wave generation periods to effect on a body with hypertension, so as to relieve hypertension by the specific energy wave.
Hypertension Patent Pack
Download 166+ patent application PDFs
Hypertension Patent Applications
Download 166+ Hypertension-related PDFs
For professional research & prior art discovery
inventor
  • 166+ full patent PDF documents of Hypertension-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Inhibitors of the renal outer medullary potassium channel
Merck Sharp & Dohme Corp.
January 11, 2018 - N°20180009807

The present invention provides compounds of formula i (i) and the pharmaceutically acceptable salts thereof, which are inhibitors of the romk (kir1. 1) channel. The compounds may be used as diuretic and/or natriuretic agents and for the therapy and prophylaxis of medical conditions including cardiovascular diseases such as hypertension, heart failure and chronic kidney disease and conditions associated with excessive ...
Treatment of right ventricular dysfunction due to pressure overload
Ottawa Hospital Research Institute
January 11, 2018 - N°20180008673

A method is disclosed for inducing right ventricular (rv) adaptive remodeling in a patient suffering from pulmonary hypertension (ph) due to pressure overload comprising administering a therapeutically effective amount of a carditrophin-1 polypeptide, recombinant protein or a polynucleotide encoding ct-1 polypeptide or full-length protein.
Anti-activin a antibodies and methods of use thereof for treating pulmonary arterial hypertension
Regeneron Pharmaceuticals, Inc.
January 11, 2018 - N°20180008672

The present invention provides anti-activin a antibodies, and antigen-binding fragments thereof, as well as methods of use of such antibodies, or antigen-binding fragments thereof, for treating a subject having pulmonary arterial hypertension (pah).
Compositions and methods for preventing or treating pulmonary hypertension
The Regents Of The University Of Colorado, A Body Corporate
January 11, 2018 - N°20180008662

The present invention provides a method of treating and/or preventing pulmonary hypertension in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of a bioactive peptide preparation derived from at least one botanical source.
Pharmaceutical compositions for combination therapy
Intercept Pharmaceuticals, Inc.
January 11, 2018 - N°20180008616

The present invention relates to a pharmaceutical composition comprising a combination of an fxr agonist and at least one lipid lowering agent (e. G., ppar-alpha agonist, ppar-delta agonist, ppar-alpha and delta dual agonist, and/or statin). Also disclosed is use of the combination for the treatment or prevention of a fxr mediated disease or condition, such as primary biliary cirrhosis (...
Methods and agents for treating disease
Angion Biomedica Corp.
January 04, 2018 - N°20180002324

The present invention provides compounds having the general structural formula (i) [formula should be inserted here] and pharmaceutically acceptable derivatives thereof, as described generally and in classes and subclasses herein, and additionally provides pharmaceutical compositions thereof, and methods for the use thereof for the treatment of any of a number of conditions or diseases involving elevated levels of aldosterone or ...
1,3-dihydroimidazole-2-thione derivatives as inhibitors of dopamine-beta-hydroxylase
Bial - Portela & Ca, S.a.
December 28, 2017 - N°20170369478

Compounds of formula i and a method for their preparation are described, where r1, r2 and r3 are the same or different and signify hydrogens, halogens, alkyl, nitro, amino, alkylcarbonylamino, alkylamino or dialkylamino group; r4 signifies -alkyl-aryl or alkyl heteroaryl; x signifies ch2, oxygen atom or sulphur atom; n is 2 or 3; including the individual (r)- and (s)-enantiomers or ...
1,3-dihydroimidazole-2-thione derivatives for use in the treatment of pulmonary arterial hypertension and lung injury
December 28, 2017 - N°20170369477

For use in treating pulmonary arterial hypertension and associated conditions, where r1, r2 and r3 are the same or different and signify hydrogens, halogens, alkyl, alkylaryl, alkyloxy, hydroxy, nitro, amino, alkylcarbonylamino, alkylamino or dialkylamino group; r4 signifies hydrogen, alkyl, -alkylaryl or -alkylheteroaryl; x signifies ch2, oxygen atom or sulphur atom; n is 1, 2 or 3, with the proviso that when n is 1, ...
Loading